249 related articles for article (PubMed ID: 7513153)
1. Recent trends in rifamycin research.
Lal R; Lal S
Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
[TBL] [Abstract][Full Text] [Related]
2. Rifamycins: strain improvement program.
Lal R; Khanna M; Kaur H; Srivastava N; Tripathi KK; Lal S
Crit Rev Microbiol; 1995; 21(1):19-30. PubMed ID: 7576149
[TBL] [Abstract][Full Text] [Related]
3. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
Gill SK; Garcia GA
Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex].
Yamamoto T; Amitani R; Kuze F; Suzuki K
Kekkaku; 1990 Dec; 65(12):805-10. PubMed ID: 2127615
[TBL] [Abstract][Full Text] [Related]
6. [RNA polymerase-rifamycin. A molecular model of inhibition].
Chertov OIu; Obukhov AN; Lipkin VM
Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
Saito H; Sato K; Tomioka H
Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
[No Abstract] [Full Text] [Related]
8. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
McMillian R; Medoff G; Schlessinger D; Kobayashi GS
Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
11. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
Tomioka H
Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623
[TBL] [Abstract][Full Text] [Related]
12. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
Pattyn SR; Hébrant F
Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
[TBL] [Abstract][Full Text] [Related]
14. [In vivo activities of new rifamycin derivatives against mycobacteria].
Kuze F; Yamamoto T; Amitani R; Suzuki K
Kekkaku; 1991 Jan; 66(1):7-12. PubMed ID: 2013969
[TBL] [Abstract][Full Text] [Related]
15. [Current status and perspectives on the development of rifamycin derivative antibiotics].
Hidaka T
Kekkaku; 1999 Jan; 74(1):53-61. PubMed ID: 10067056
[TBL] [Abstract][Full Text] [Related]
16. A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
Xiong Y; Wu X; Mahmud T
Chembiochem; 2005 May; 6(5):834-7. PubMed ID: 15791687
[No Abstract] [Full Text] [Related]
17. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases.
O'Brien RJ; Lyle MA; Snider DE
Rev Infect Dis; 1987; 9(3):519-30. PubMed ID: 3037676
[TBL] [Abstract][Full Text] [Related]
18. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
[TBL] [Abstract][Full Text] [Related]
19. Rifamycin antibiotics and the mechanisms of their failure.
Adams RA; Leon G; Miller NM; Reyes SP; Thantrong CH; Thokkadam AM; Lemma AS; Sivaloganathan DM; Wan X; Brynildsen MP
J Antibiot (Tokyo); 2021 Nov; 74(11):786-798. PubMed ID: 34400805
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures.
Krishna PS; Venkateswarlu G; Pandey A; Rao LV
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):311-5. PubMed ID: 12546705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
